• picture

What is NEO-CIRC?

Neo-Circ Consortium

NEO-CIRC:

- will focus on the use of the drug dobutamine for the treatment of circulatory failure in the first two days after birth

- sustained low blood pressure and impaired blood flow to organs, during this period, can cause brain injury resulting in poor neurodevelopmental outcomes

- neurodevelopmental disorders are associated with mental, emotional and physical disorders of varying severity

- there is strong evidence that the use of dobutamine will reduce the incidence of these disabilities

read more >>

Latest news

3rd Prize for Poster at RANM 2017 Conference
Kirstin Faust (University of Lubeck) awarded joint 3rd Prize for best poster presentation at RANM 2017 Conference

NEOCIRC 003 TRIAL: Additional study centres required
We are now recruiting additional study centres to conduct a large randomised study in infants < 33 weeks gestation.

NeoCirc-001A completed!
The 1st phase of NEOCIRC001 trial is complete after recruiting the required number of babies.

View all news >>

Events

NEO-CIRC - HIP Trial Consensus Meeting Madrid September 2018

A joint meeting was held with the HIP Trial Consortium in Madrid in September 2018.

7th NEO-CIRC Consortium Meeting Budapest May 2018

The 7th NEO-CIRC Consortium Meeting was held in Budapest on the 23rd and 24th May 2018.

5th NEO-CIRC Consortium Budapest - January 2016

On the 25th and 26th of January 2016, the Neocirculation Consortium held its Consortium Meeting in Budapest chaired by Heike Rabe the Project Coordinator

View all events >>